August 20, 2014 - ASM Comments to FDA on Rapid Influenza Test Classification

ASM commented on an FDA proposal to reclassify antigen based rapid influenza virus antigen detection test systems intended to detect influenza virus directly from clinical specimens.

Read more...

ASM Statement on Dual Use Research of Concern and Biosafety

The ASM sent a statement to ASM members on Dual Use Research of Concern and Biosafety.

Read more...

July 21, 2014 - ASM Letter Regarding the Accelerating Biomedical Research Act

The ASM sent a letter to Senator Tom Harkin thanking him for the Accelerating Biomedical Research Act and his leadership regarding funding for the National Institutes of Health.

Read more...

July 30, 2014 - Historical Background Related to Select Agents

The ASM has prepared a history related to select agents.

Read more...

July 14, 2014 - ASM Provides Comments on the Protecting Access to Medicare Act to CMS

ASM provided comments to the Centers for Medicare & Medicaid Services (CMS) regarding Section 1834A, “Improving Policies for Clinical Diagnostic Laboratory Tests,” added to the Social Security Law by the Protecting Access to Medicare Act of 2014 (PAMA).

Read more...

TPL_asm2013_SEARCH